Versant Ventures Gets Exit At Oculeve

San Diego-based venture investor Versant Ventures has scored an exit out of its portfolio, with the acquisition of Oculeve, a medical device developer developing treatments for dry eye disease. Oculeve was acquired for $125M plus earnout by Allergan this morning. Oculeve, which was based in South San Francisco, had raised $7.5M in funding from Kleiner Perkins Caufield & Byers, New Enterprise Associates and Versant Ventures.